ADVANCED GASTRIC CANCER
Clinical trials for ADVANCED GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo teams up with chemo to fight advanced stomach cancer
Disease control Recruiting nowThis study is testing whether adding a new two-drug immunotherapy (called QL1706) to standard chemotherapy works better for people with advanced stomach or gastroesophageal junction cancer who haven't had prior treatment. About 32 participants will receive the combination therapy…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new pill to boost stomach cancer treatment
Disease control Recruiting nowThis study is testing whether adding a new oral medication (SHR2554) to a standard immunotherapy-plus-chemotherapy combo works better for advanced stomach cancer. It will enroll 36 adults who have not yet received treatment for their advanced disease. The goal is to see if this t…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug targets common cancer driver in major trial
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new drug called BGB-53038. It targets a specific genetic change (KRAS mutation) found in many advanced solid tumors like lung, colorectal, and pancreatic cancers. The drug will be tested alone and in c…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Drug attack targets Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new combination of two cancer drugs, disitamab vedotin and tucatinib, for people with advanced or spreading breast or stomach cancer. The main goals are to find a safe and effective dose and to see if the combination can shrink tumors. It is for people who…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug combo trial offers hope for advanced stomach cancer patients
Disease control Recruiting nowThis study is testing whether adding a new oral drug called SHR2554 to other cancer treatments is safe and effective for people with advanced stomach cancer that has spread or cannot be removed by surgery. It will involve about 351 adults with this condition. The main goals are t…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Personalized cancer vaccine trial seeks to train Body's own defenses
Disease control Recruiting nowThis early-stage trial is testing a two-part personalized treatment for advanced stomach cancer that has stopped responding to standard therapies. It combines a custom-made vaccine designed to target a patient's specific tumor with an infusion of specially trained immune cells. T…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE1 • Sponsor: Jia Wei • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Smartphone app aims to ease Chemotherapy's harsh side effects
Symptom relief Recruiting nowThis study is testing whether a smartphone app, combined with remote nurse support, helps people with cancer better manage the side effects of their chemotherapy. Over 400 adults with stomach, lung, breast, or colon cancer will use the app to track symptoms and get guidance. The …
Matched conditions: ADVANCED GASTRIC CANCER
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Scientists hunt for clues to make cancer drugs work better for more people
Knowledge-focused Recruiting nowThis international study aims to find better ways to predict which patients with advanced breast, lung, bladder, or stomach cancer will benefit from a newer type of targeted cancer drug called antibody-drug conjugates (ADCs). Researchers will collect blood and tumor samples from …
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC